Director Howard Welgus proposes selling 4,728 Arcutis (ARQT) shares around November 16.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Arcutis Biotherapeutics, Inc. director Howard Welgus has proposed selling 4,728 common shares of the company, with an approximate sale date of November 16, 2026, and an aggregate market value of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context